| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | #f | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/27/25 19:56 | 7/29/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Accardi Mario Alberto | X0 | O | P,Orexin | 5 | S.d | -852 | 18.32 | 0 | -46 | 216 | D | |||||||||||||||
| 10/16/25 16:13 | 8/15/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 12 | S.dm | -3,112 | 17.51 | 0 | -178 | 131 | D | |||||||||||||||
| 9/24/25 19:00 | 2/3/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Bush Tia L | X0 | O | Chief Te | 4 | S.dm | -2,549 | 20.69 | 0 | -123 | 148 | D | |||||||||||||||
| 7/25/25 18:24 | 7/25/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Weinhoff Gregory M | X0 | O | Chief Bu | 14 | S.dm | -3,155 | 15.14 | 0 | -208 | 223 | D | |||||||||||||||
| 7/21/25 19:39 | 7/21/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Saha Saurabh | X0 | DO | CEO | 17 | S.dm | -15,142 | 15.77 | 0 | -960 | 862 | D | |||||||||||||||
| 3/19/25 16:47 | 3/17/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Chao David M | X0 | O | Chief Ad | 1 | S.d | -120 | 17.17 | 0 | -7 | 225 | D | |||||||||||||||
| 2/10/25 17:33 | 2/7/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Anderson Karen M. | X0 | O | Chief Pe | 3 | S.dm | -982 | 18.21 | 0 | -54 | 72 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |